Elizabeth Bailey is a Managing Director at Rhia Ventures/RH Capital, a venture capital fund investing in companies that are transforming women’s reproductive health by improving access, quality, choice and affordability of care for all women. Elizabeth has over 15 years of experience in venture capital and supporting early-stage technology companies. She was a Partner at one of the first impact investment funds (Commons Capital LP), where she managed the healthcare and education portfolios, which included: Claros Diagnostics (acquired by OPKO), CodeRyte (acquired by 3M), Combinent Biomedical Systems, HistoRx (acquired by Genoptix), Medical Metrx Solutions (acquired by AIG), TelaDoc Medical Services (IPO:TDOC), Valeo Medical, and Apex Learning (acquired by Education Growth Partners). Elizabeth also served as the Founding Director of the Consortium for Affordable Medical Technologies (CAMTech) at Massachusetts General Hospital, where she built a global program to accelerate medtech innovation and catalyze new health startups. Throughout her career, Elizabeth has been a passionate advocate of the power of business – from startups to multinationals – to drive social change. Elizabeth earned a Master’s in Public Policy from Harvard University’s Kennedy School of Government and a BA from Brown University.